Home » Topics » Regulatory

Regulatory
RSS

Increased dose strengths of Raxar now available in single-therapy box

Nov. 19, 1998

Lamivudine highlighted at recent Study for Liver Diseases meeting

Nov. 18, 1998

ML Laboratories granted second license from U.K. authorities for its dry powder inhaler

Nov. 17, 1998

Nolvadex now available for breast cancer prevention

Nov. 17, 1998

New oral ultrasound contrast agent approved by FDA

Nov. 17, 1998

Improved dosage form of selegiline now on the U.K. market

Nov. 11, 1998

ATTRACT study establishes efficacy, safety of infliximab in RA patients

Nov. 11, 1998

FDA approves Actiq for treatment of breakthrough cancer pain

Nov. 6, 1998

First Neoral equivalent cleared by FDA

Nov. 4, 1998

U.S. grants first approval for GelTex's novel phosphate-binding polymer therapeutic

Nov. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...